New Woodlands storefront brings hologram technology to the car-shopping experience

vr-oom

The Woodlands Mall shoppers can schedule virtual test drives, complete purchases, schedule deliveries of vehicles and meet with staff at this new high-tech store. Photo courtesy of JLL

The Woodlands-based online pre-owned car purveyor evrdrive has opened its flagship Customer Experience Center, or CXC, at The Woodlands Mall.

Designed by JLL Design Solutions, the modern space will allow shoppers to virtually tour the company's fleet of vehicles through its evrViewTM 3D hologram technology. According to a release, the technology can show evrdrive's full inventory of SUVs, cars, trucks, or other body styles and can display the vehicle's model specifications and history.

From the storefront, shoppers can also schedule virtual test drives, complete purchases, schedule deliveries of vehicles and meet with staff.

"We believe evrdrive is the future of automotive retail, and we are committed to providing our customers with a seamless and enjoyable shopping experience," Brian Singh, CEO of evrdrive, said in a statement.

evrdrive was founded in 2022, according to LinkedIn, and is part of Foundation Automotive Corp, a Houston-based company that owns car dealerships in the U.S. and Canada.

The company also runs a 55,000-square-foot Reconditioning Hub in the Houston area where vehicles are inspected and refurbished.

A number of new innovative auto ventures have rolled into Houston in recent months.

Self-driving ridehailing service Cruise expanded into Houston with its all electric, driverless cars in early May. The company launched services in Austin at the start of the year.

Uber Technologies, Inc. and Nuro also partnered last September to provide autonomous, electric vehicles for food deliveries in Houston. That same month, Drvn, a global on-demand chauffeur service, began operating in the Bayou City.

Drvn offers tech-savvy service, high-end cars, and various ride options. Photo courtesy of drvn

New tech-enabled chauffeur service stretches into Houston with upscale ride options

stay classy

Discriminating Houstonians who opt for luxury/executive car services (and who don’t, unfortunately, have a limo and driver of their own) now can choose an innovative, tech-savvy option.

Drvn, a global chauffeur service, has just rolled into Houston. Customers can look forward to on-demand rides — 24 hours a day — in various, upscale vehicles. Options start with first class; cars offered include sedans (Mercedes S Class, BMW 7 Series, or similar); SUVs (Cadillac Escalade, Lincoln Navigator, or similar); and even vans (such as the Mercedes 1500).

Business class also offers sedans (Cadillac XTS, Lincoln Continental, or similar); SUVs (Chevrolet Suburban, Ford Expedition, or similar); and also vans (Ford Transit or similar).

Private charters for posh parties or travel parties include Grech minibuses (or similar) that can seat up to 36 passengers. Limousines are available upon request and subject to availability. All vehicles are black, for a more classic touch.

Just in time for society/gala season, drvn offers locals rides to events all around Greater Houston, as well as both major airports. (Drvn’s CEO David Medina tells CultureMap that the service is a hit in its Coral Gables, Florida headquarters, where well-heeled customers use it for event travel.)

Other service areas include port transfers to and from the Port of Galveston; drvn’s long-distance car service to Dallas; Oklahoma City; Shreveport, Louisiana; Baton Rouge, Louisiana; Little Rock, Arkansas; and beyond. Drvn staff expects major demand for events, conventions, and conferences, plus executive car service for business clients.

Currently, those interested can book rides via the drvn site. Medina notes that a customer app is scheduled for later this year.

As for the cost: A simple search from the Memorial Park area to Bush Intercontinental Airport yielded point-to-point rides starting at around $226 in an executive class sedan. Users can also schedule and even request special cars and opt for hourly service (perfect for weddings, occasions, and that visiting celebrity friend).

Aiming to separate itself from local high-end car services, drvn promises “five-star, white-glove transportation” options, cutting-edge booking technology, and drivers who meticulously train and even undergo secret rides from drvn staff to assure quality control. Drvn hopes to entice business/executive car service clients with tech such as God’s view and GPS tracking (to keep tabs on the boss’s car), a live manifest, and uniform billing and communication.

Medina also hopes to separate his company by redefining what luxury actually means when it comes to car service.

“‘Luxury’ does not mean luxury for high-end private car service,” he says. “Luxury is a Flying Spur or a Bentayga, not a Mercedes S Class or an Escalade. But, a Bentley is not what is in the mind of professionals who seek ‘luxury’ private car service. It is a state of being. It is knowing, without saying, that your chauffeur not only has your best interests in mind, he has your experience in mind. It is part of his duty of care to know what you expect and deliver it with elegance and with no visible exertion. It is through the simplicity of this balance that drvn’s chauffeured service delivers a ‘luxury’ experience. Not the Bentley.”

------

This article originally ran on CultureMap.

NuVinAir ReKlenz-X is safe for use in vehicles and can be used without damaging the interior. Photo courtesy of NuVinAir

New product sold in Houston gets EPA approval as eco-friendly, coronavirus-killing car cleaner

IN-CAR TECH

With the onset of COVID-19, the public is more aware than ever of cross-contamination, which extends from your home to your business to your car, and beyond.

NuVinAir announced that its latest product, ReKlenz-X, has gotten approval from the Environmental Protection Agency (EPA) as an eco-friendly disinfectant. The company's Houston affiliate, Brian Ross, is selling the product.

ReKlenz-X kills 99.9 percent of germs, bacteria, and viruses in a vehicle's interior without compromising the integrity of the cabin. The product is on the EPA's "List N", which includes disinfectants for use to combat SARS-CoV-2, the virus that causes COVID-19."NuVinAir has proudly been at the forefront of helping ensure healthier commutes to drivers and passengers since launching in 2015. Adding this EPA-approved, oxygen-infused product that actually kills what's behind the coronavirus gives us an exciting extension to our 'Total Health' application," says Kyle Bailey, NuVinAir Global's CEO and founder.

"Our science-backed ReKlenz-X disinfectant cleans, protects, and disinfects safely and effectively — it's everything our automotive partners need in guaranteeing their customers' confidence in a safer, healthier vehicle," he continues.

To clean, the proprietary product uses an oxygen-enriched formula to quickly kills bacteria and viruses by destroying their cell walls through a process called oxidation. According to NuVinAir, ReKlenz-X contains no harsh chemicals, sticky residue, or dangerous volatile organic compounds. The result is a disinfected vehicle with no chemical smell.

ReKlenz-X is available in 32-ounce spray bottles through automotive dealerships, detail shops, rental-car companies, service centers, and vehicle fleets.

"Until now, any possible solution for killing the coronavirus was wrought with harmful chemicals, expensive equipment, and residue-leaving application devices that destroy the vehicle's interior," said Troy Blackwell, Chief Operating Officer for NuVinAir Global. "As a disinfectant and sanitizer, it can be applied to all interior vehicle surfaces using a microfiber towel. Paired with our premier detailing solution, ReNuSurface, as well as our patented Cyclone treatment, it takes deep cleaning to a whole new level for our automotive partners and their customers."

Dallas, Texas-based NuVinAir sells their products through a franchise system, similar to Line-X's business model.

------

This article originally ran on AutomotiveMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

3 Houston incubators and accelerators fueling the growth of local startups

Meet the finalists

It takes a village to launch a business. That's where Houston's network of incubators and accelerators can step in, providing the resources, mentorship and community needed to push a fledgling company forward.

As part of our 2026 Houston Innovation Awards, the Incubator/Accelerator of the Year category honors a local organization that is championing and fueling the growth of Houston startups.

Three incubators and accelerators have been named finalists for the 2026 award. They support startups ranging from hard-tech companies to food and youth concepts.

Read more about these organizations below. The 2026 winners will be announced on InnovationMap.com in mid-November.

Activate

Hard tech incubator Activate supports scientists in "the outset of their entrepreneurial journey." The Houston hub was introduced in 2024, and joins others in Boston, New York, and Berkley, California—where Activate is headquartered. It named its third Houston cohort this summer.

The two-year program graduated its first class of Houston fellows in 2026 and saw its first alumni IPO from Houston-based Fervo Energy, which previously participated in a Berkley cohort. Nationally, it has supported 346 fellows and 276 companies since 2015. Those companies have raised more than $6 billion in follow-on funding, according to Activate. In Houston, it has supported Houston startups like Solidec, FlowCellutions and Orbital Arc. Activate Houston is led by managing director Jeremy Pitts, who co-founded Greentown Labs in Boston. It is based out of the Ion.

Impact Hub Houston

Impact Hub Houston supports early-stage ventures at various stages of development through innovative programs that address pressing societal issues. The nonprofit organization supports social impact startups through mentorship, connections and training opportunities.

There are more than 110 Impact Hubs globally with members spanning 72 countries. Launched in 2018, Impact Hub Houston says its membership tripled by the beginning of 2026. This year brought major milestones for the community, including the launch of its Ideas to Impact Accelerator, which supported 11 founders across the health, education, food systems, civic technology and workforce development sectors. It also received funding from more than 20 international Impact Hubs to develop SYNC, a collaboration platform that 25 Impact Hubs across five continents have committed to pilot. The organization has worked with local startups including Myoviva Health, The Change Lab and INNERVERSE Inc.

MarMo Innovation

Galveston-based business incubator MarMo Innovation is focused on removing barriers to entrepreneurship. It aims to provide affordable space, education, mentorship, market access, connections and real-world opportunities that help entrepreneurs move from idea to launch to sustainable growth. The "industry-agnostic" incubator was founded in 2022 and is led by Executive Director Erica Delgadillo.

This year, the organization moved from primarily serving as a coworking and community space into a more comprehensive entrepreneurial incubator by expanding its MarMo Market, MarMo Market Jr. and Lunch LineUp programs. A major focus for MarMo is food entrepreneurship. It is developing an Incubator Kitchen, which MarMo says will support programs like its Cottage to Commercial Bootcamp and Food Biz 101. The organization also expanded its board this year and says it is diversifying its revenue through memberships, events, markets, equipment and space rentals, sponsorships, grants and new entrepreneurial programming.

Baylor College of Medicine launches VC fund to invest in biotech startups

fresh funding

Houston’s Baylor College of Medicine just unveiled a new venture capital fund that backs early-stage biotech startups—and it’s already made its first investment.

BCM Legacy Fund I, funded by philanthropies, invested an undisclosed amount in Houston biotech startup Nemea Therapeutics. Nemea, a spinout of the Baylor College of Medicine and Germany’s Lead Discovery Center, is developing an oral drug to treat metastatic triple-negative breast cancer that no longer responds to currently available therapies.

This type of aggressive cancer spreads from the breast to other areas of the body, such as the bones, liver, lungs or brain. Roughly 38,000 to 57,000 Americans are diagnosed each year with metastatic triple-negative breast cancer. One study showed about half of patients survive past the one-year mark following diagnosis and about one-third survive two years.

“Baylor College of Medicine’s laboratories produce discoveries with the potential to change patients’ lives, and too many of them stall where academic funding ends and private investment has not yet begun,” Dr. Jakub Tolar, president, CEO and executive dean of the Baylor College of Medicine, said in a press release. “The BCM Legacy Fund fills that gap, giving our scientists a path to advance their discoveries to patients.”

The National Institutes of Health awards more than $36 billion per year for biomedical research in the U.S., Baylor said. But some biomedical discoveries “never leave the starting line because they don’t yet fit the economics of venture capital,” the college said.

“The forefront of a new model”

The BCM Legacy Fund aggregates philanthropic capital from private foundations and donor-advised funds. It then invests in startups so they can move beyond that starting line and into later-stage investment rounds. The Greater Houston Community Foundation is the fund’s philanthropic partner.

“It’s exciting to be on the forefront of a new model for philanthropic capital,” said Houston entrepreneur and investor Burton Hanson, managing partner of the fund.

“Not only do we hope to solve a real problem by advancing these therapies to the patients who need them most, but we also hope this model will inspire others in the city and beyond toward philanthropic creativity and a posture of ‘I sacrifice; we win.’”

The fund expects to invest in about 15 early-stage startups over a five-year span. Baylor declined to divulge the amount of money in the fund and the size of the investment in Nemea.

Nemea’s “world-class chemistry”

Hanson oversees the Baylor fund alongside Chicago investor Steve Lehmann, who led the University of Chicago’s Innovation Fund.

Lehmann said Nemea, the fund’s first portfolio company, “has world-class chemistry, Baylor biology, and patients with no good options. Our job is to fund the experiments that carry it to the next handoff, so that industry and later-stage investors can take it from there.”

Based at Houston’s massive Texas Medical Center, Nemea plans to start clinical trials next year in collaboration with Baylor’s Lester and Sue Smith Breast Center.

Nemea previously received $9 million from the Lead Discovery Center and a $1.6 million grant from Baylor. Last year, the startup said it was seeking $25 million to $30 million in seed and Series A funding.

Debra McCoy of Houston, a former managing director at BlackRock and former partner at Bain & Co., and Paul Thomas, co-founder and CEO of Spring-based benefits manager Luscinia Health, sit on the Baylor fund’s governing board. Dr. Paul Klotman, former president, CEO and executive dean of Baylor, is a senior strategic adviser.

How does the fund find investment targets?

The Baylor Legacy Fund relies on two tools to help unearth early-stage biotech startups:

  • High-resolution “innovation maps” of research institutions. These maps surface hidden clusters of innovation, identify rising-star researchers and tie pockets of “innovation supply” at Baylor to areas of “innovation demand” in biotech.
  • AI-enhanced due diligence. AI agents assist with due diligence of early-stage biotech startups. The fund says the platform “distills the frameworks we’ve developed over a decade of teaching and investing into a flexible … diligence environment.”

MD Anderson unveils $3.4B expansion with two new Houston cancer care facilities

major expansion

The cutting edge of cancer-fighting technology and science is getting even sharper after MD Anderson announced last week that it will open two new facilities in the Texas Medical Center within the next five years. Inspiration Tower and Prism will expand MD Anderson’s annual patient load in the TMC to 250,000 annually and will incorporate a variety of new techniques.

The $3.4 billion project will add 2 million square feet to MD Anderson's TMC footprint, bringing its total campus size to 22 million square feet by 2032. Located at the corner of Fannin Street and Holcombe Boulevard, the cancer center says the two new facilities will serve as its new "front door" to the TMC.

“Every detail of these buildings, from the technology to the treatment rooms, was designed around our patients who will receive their care in them and our employees who will work in them. The facilities will serve as a physical representation of hope for the patients and their families who will walk through the doors,” Dr. Jeffrey E. Lee, president ad interim of UT MD Anderson, said in a news release. “Inspiration Tower and Prism are the future of cancer care, and we are grateful for the longstanding support and guidance we’ve received from the UT System Board of Regents to bring these projects to life. These facilities are part of the most impactful capital expansion in UT MD Anderson’s history.”

Prism is especially exciting as it will represent fully half of the linear accelerator treatment in the TMC. Linear accelerator is a radiation treatment that uses magnetically charged fields to deliver targeted external radiation therapy, like shooting cancer with a rail gun. The treatment is safer and has fewer side effects than older radiation treatments.

In addition, Prism will contain 12 MRI machines, four CT scanners, two PET-CT units, 18 radiation vaults and seven radiation simulators. Patient comfort has also been put at a premium with multiple gardens and roof overlooks.

“Every patient we treat deserves an environment that reflects the excellence of the care they receive at UT MD Anderson,” Chris McKee, executive vice president and chief strategy officer at UT MD Anderson, added in the release. “Our new facilities will be innovative, agile, adaptable and beautiful, and they will allow us to care for more patients, more effectively – in an environment that enhances healing and well-being. We are building for our future and for every patient who will be counting on us.”

Prism is slated to open in 2030.

Inspiration Tower will have 25 floors of surgical, diagnostic, and treatment services. At 1.4 million square feet, it’s currently expected to be the largest cancer-specific treatment facility in the United States. The tower will be divided into units for specific types of cancer, making it easy to integrate the advancing research being done all over Houston.

Like Prism, Inspiration Tower is specifically designed to offer comfort and reassurance, with more garden space, terraces, and beautiful scenery to ease patient distress. It is expected to open in 2032.

View All Listings